ELISA Assay Kit for Anti-CTLA-4 h-mAb in Human Serum

How a therapeutic antibody is metabolized in the body is pertinently relevant to its efficacy. Therefore, pharmacokinetics study is an important part of the drug development. CTLA-4 is probably the most targeted molecule in today¡¦s pharmaceutical industry, thanking to the clinical success of Yervoy?. Many investigational anti-CTLA-4 mAbs are being developed. There is a growing need for a standard assay that can be used to facilitate the study of their pharmacokinetics.